Paradigm Biopharmaceuticals (PBIGF) Revenue

17 Followers

Paradigm Biopharmaceuticals Revenue

Paradigm Biopharmaceuticals had a revenue of 55.00K in the quarter ending Jun 30, 2026, with 118.69%. This bring the company's revenue in the last twelve months to 80.15K, Decreased 32.33%. In the fiscal year ending Jun 30, 2026, Paradigm Biopharmaceuticals had annual revenue of 80.15K with 53.78% growth.

Revenue (ttm)

80.15K

Revenue Growth

64.49%

P/S Ratio

1339.56

Revenue/Employee

$6,679

Employees

Market Cap

$107.37M

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Jun 30, 2026	80.15K	28.03K	+53.78%
Jun 30, 2025	52.12K	-13.68K	-20.79%
Jun 30, 2024	65.80K	19.04K	+40.72%
Jun 30, 2023	46.76K	-32.46K	-40.98%
Jun 30, 2022	79.22K	58.67K	+285.52%
Jun 30, 2021	20.55K	―	+∞%
Jun 30, 2020	―	-2.98M	-100.00%
Jun 30, 2019	2.98M	301.00K	+11.22%
Jun 30, 2018	2.68M	860.00K	+47.17%
Jun 30, 2017	1.82M	―	―